5 Headache and Migraine News Highlights from the past 3 Months (July 2019 edition)
Here are the five posts most-read by visitors to Headache and Migraine News. The most popular posts come first. Thanks for reading! Feel free to leave your comments and join the conversation.
- New Approaches to “Aggressive” Migraine Treatment – Migraine symptoms are sometimes “endured” for months or years without serious focus on treatment. Many people are being told that migraine is “normal” and that they just have to “put up with it” and “take an aspirin” . . .
- “First FDA-approved drug that reduces the frequency of attacks of episodic cluster headache” – Earlier this month in the USA, the FDA approved Emgality (galcanezumab) for use with episodic cluster headache. This is a big step for CGRP inhibitors, which have shown promise for treating both migraine and cluster . . .
- More News on Baby Colic and Migraine – It’s news, but it mostly isn’t news. A new study published in the journal Headache confirms again that there’s a link between colic in babies and migraine . . .
- Doctors too “abrupt” as they apply Opioid Restrictions? – In 2016, the Centers for Disease Control and Prevention (CDC) in the USA implemented new guidelines for restrictions of opioid medications. Now, as the results of the restrictions are coming to light, the CDC is expressing concern that doctors may be taking the restrictions too far . . .
- Does Migraine Increase Pregnancy Risks? – A study out of Denmark, published last month in the journal Headache, is raising serious concerns about the link between migraine and certain pregnancy risks. How can mothers with migraine give their babies the best possible opportunities for good health? . . .